Regulatory News
Monday, November 21, 2016
Mylan declines Senate committee request to testify about EpiPen
Nov 21 (Reuters) - Mylan NV has declined a U.S.
Senate committee request to testify about a $465 million pending
settlement to resolve charges the company underpaid government
healthcare programs by...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment